Literature DB >> 11371575

Invariant chain induces B cell maturation by activating a TAF(II)105-NF-kappaB-dependent transcription program.

D Matza1, O Wolstein, R Dikstein, I Shachar.   

Abstract

Early stages of B cell development occur in the bone marrow, resulting in formation of immature B cells. From there these immature cells migrate to the spleen where they differentiate to mature cells. This final maturation step is crucial for the B cells to become responsive to antigens and to participate in the immune response. Recently, invariant chain (Ii), a major histocompatibility complex class II chaperone, as well as the transcription factors c-Rel and p65/RelA, were found to play a role in the final antigen-independent differentiation stage of B cells in the spleen. In this study, we investigated a possible link between Ii-dependent B cell maturation and the NF-kappaB pathway. Our studies indicate that Ii-induced B cell maturation involves activation of transcription mediated by the NF-kappaB p65/RelA homodimer and requires the B cell-enriched coactivator TBP-associated factor (II)105.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11371575     DOI: 10.1074/jbc.M104684200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

1.  Invariant chain induces B cell maturation in a process that is independent of its chaperonic activity.

Authors:  Didi Matza; Frida Lantner; Yoel Bogoch; Liat Flaishon; Rami Hershkoviz; Idit Shachar
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

2.  The cytokine midkine and its receptor RPTPζ regulate B cell survival in a pathway induced by CD74.

Authors:  Sivan Cohen; Or-yam Shoshana; Einat Zelman-Toister; Nitsan Maharshak; Inbal Binsky-Ehrenreich; Maya Gordin; Inbal Hazan-Halevy; Yair Herishanu; Lev Shvidel; Michal Haran; Lin Leng; Richard Bucala; Sheila Harroch; Idit Shachar
Journal:  J Immunol       Date:  2011-12-02       Impact factor: 5.422

3.  CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex.

Authors:  Xuerong Shi; Lin Leng; Tian Wang; Wenkui Wang; Xin Du; Ji Li; Courtney McDonald; Zun Chen; James W Murphy; Elias Lolis; Paul Noble; Warren Knudson; Richard Bucala
Journal:  Immunity       Date:  2006-10       Impact factor: 31.745

4.  The chondroitin sulfate form of invariant chain trimerizes with conventional invariant chain and these complexes are rapidly transported from the trans-Golgi network to the cell surface.

Authors:  Lynne S Arneson; Jim Miller
Journal:  Biochem J       Date:  2007-08-15       Impact factor: 3.857

Review 5.  Investigational immunotherapeutics for B-cell malignancies.

Authors:  Alfonso Quintás-Cardama; William Wierda; Susan O'Brien
Journal:  J Clin Oncol       Date:  2010-01-04       Impact factor: 44.544

6.  Molecular cloning and expression of two chicken invariant chain isoforms produced by alternative splicing.

Authors:  Dalian Zhong; Weiyi Yu; Yuhua Liu; Jing Liu; Jinnian Li
Journal:  Immunogenetics       Date:  2004-11-16       Impact factor: 2.846

Review 7.  Antibody-Drug Conjugates for the Treatment of Hematological Malignancies: A Comprehensive Review.

Authors:  Cédric Rossi; Marie-Lorraine Chrétien; René-Olivier Casasnovas
Journal:  Target Oncol       Date:  2018-06       Impact factor: 4.493

8.  CD74 is a member of the regulated intramembrane proteolysis-processed protein family.

Authors:  Shirly Becker-Herman; Galit Arie; Helena Medvedovsky; Anat Kerem; Idit Shachar
Journal:  Mol Biol Cell       Date:  2005-08-17       Impact factor: 4.138

9.  A retroviral mutagenesis screen identifies Cd74 as a common insertion site in murine B-lymphomas and reveals the existence of a novel IFNgamma-inducible Cd74 isoform.

Authors:  Magdalena Pyrz; Bruce Wang; Matthias Wabl; Finn Skou Pedersen
Journal:  Mol Cancer       Date:  2010-04-23       Impact factor: 27.401

10.  Mad3 negatively regulates B cell differentiation in the spleen by inducing Id2 expression.

Authors:  Yael Gore; Frida Lantner; Gili Hart; Idit Shachar
Journal:  Mol Biol Cell       Date:  2010-04-07       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.